UNSPSC 51421605: Clobetasol propionate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H32ClFO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 779619577M, chemically known as 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- but more generally known as clobetasol propionate, which bears US NIH Compound Identifier 32798. European Medicines Agency schedules Clobetasol propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01346MIG.

UNSPSC 51421605 Clobetasol propionate is a Commodity code for a topical corticosteroid pharmaceutical product, but the recent state and local opportunities tagged to this code show no alignment with its nominal scope. The two most recent solicitations—one from Seminole County, Florida for naloxone and drug deactivation systems, and one from the Texas Health and Human Services Commission for direct-to-manufacturer prescription program vendor capabilities—are unrelated to clobetasol propionate, a dermatological steroid cream or ointment. The code shows little relevant recent activity under its intended pharmaceutical category, suggesting either sparse procurement demand or consistent misclassification in state and local procurement systems.

Without opportunities that reflect the actual scope of clobetasol propionate procurement, no issuing-body pattern, geographic concentration, or representative solicitation details can be identified for this specific product line. State and local governments do procure pharmaceutical inventory for health departments, community health centers, and correctional facilities, but the recent record for this code does not support a meaningful characterization of current buying patterns, jurisdictional mix, or regional activity in clobetasol propionate specifically.